Mikołaj Antkiewicz

Mikołaj Antkiewicz

Auto-generated profile, based on publicly available information

Mikołaj Antkiewicz

Ludwik Rydygier Specialist Hospital in Krakow sp. z o.o. Osiedle Złotej Jesieni 1, 31-820 Kraków

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 2026 in Quality in Sport
Verified
Journal Article
Open access
MKMartyna Kudła
Martyna Kudła
JKJulia Kociuba
Julia Kociuba
ZKZuzanna Kruczek
Zuzanna Kruczek
JSJulia Sinkowska
Julia Sinkowska
SKSzymon Kurciński
Szymon Kurciński
DKDorota Kołkowicz
Dorota Kołkowicz
Background: Osteoporosis is a global public health challenge linked to population aging and sedentary lifestyles. Non-pharmacological prevention is essential. Aim: The aim of this study was to review current scientific literature on the impact of regular sport participation on bone health, with emphasis on its role in the prevention and treatment of osteoporosis. Material and Methods: A review of publications (2021–2026) from PubMed was conducted, including meta-analyses and clinical trials on the relationship between mechanical loading and bone mineral density (BMD). Results: High-impact and multi-directional sports (volleyball, basketball) provide the most potent osteogenic stimuli. In postmenopausal women, high-intensity resistance training (80-85% 1RM) mitigates bone loss and improves Health-Related Quality of Life (HRQoL). Sport also reduces fall risk in the elderly by enhancing postural stability. Conclusions: Regular sport participation is the "gold standard" for osteoporosis prevention. Optimizing peak bone mass in youth and maintaining skeletal integrity in old age are vital. Interdisciplinary collaboration is necessary to implement these findings into public health practice.

21 December 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
AKAgata Krawczyk
Agata Krawczyk
PŁPaulina Łobaza
Paulina Łobaza
NPNatalia Pawełczak
Natalia Pawełczak
DKDorota Kołkowicz
Dorota Kołkowicz
PCPaweł Czechowicz
Paweł Czechowicz
AKAleksandra Kowal
Aleksandra Kowal
Von Willebrand disease, the most common inherited bleeding disorder, is increasingly recognized to have significant psychological comorbidities, particularly depression and anxiety. This review synthesizes current evidence from observational, cohort, and qualitative studies to examine the relationship between von Willebrand disease and mental health outcomes. Across diverse methodologies, including validated symptom scales, diagnostic coding, and pharmacotherapy records, patients with VWD consistently exhibited higher rates of depression and anxiety compared with the general population. The association remained robust across age groups and von Willebrand disease subtypes, with adolescents and women demonstrating the greatest vulnerability. Factors such as chronic pain, joint complications, abnormal uterine bleeding, and diminished quality of life emerged as significant correlates of psychological distress. These findings highlight that psychiatric morbidity in von Willebrand disease is not merely secondary to bleeding symptoms but constitutes a central aspect of disease burden, contributing to increased healthcare utilization and reduced functional capacity. Integrating psychological screening and mental health support into routine hematologic care is therefore essential to optimize long-term outcomes. Recognition of the biopsychosocial dimensions of von Willebrand disease should inform clinical management strategies, ensuring that both physical and psychological components of the disorder are comprehensively addressed.

5 May 2025 in Quality in Sport
Verified
Journal Article
Open access
PDF file
PŁPaulina Łobaza
Paulina Łobaza
MKMartyna Kudła
Martyna Kudła
GZGabriela Zając
Gabriela Zając
MAMikołaj Antkiewicz
Mikołaj Antkiewicz
AAAleksandra Arczyńska
Aleksandra Arczyńska
NPNatalia Pawełczak
Natalia Pawełczak
The COVID-19 pandemic, caused by SARS-CoV-2, has become a major global health crisis with widespread effects on healthcare, society, and economies. Initially seen as a respiratory illness, it is now recognized as a multisystem disease, with growing evidence of its impact on the nervous system. Neurological complications - such as cognitive impairment ("brain fog"), strokes, Guillain-Barré syndrome, and mood disorders - have been reported in both severe and mild COVID-19 cases, highlighting the unpredictable nature of post-COVID sequelae. These symptoms can persist long after the acute phase of infection. The mechanisms behind these effects are complex and not yet fully understood. They include direct viral invasion of the central nervous system, immune dysregulation (e.g., cytokine storm, autoimmunity), and blood–brain barrier disruption, all of which may lead to neuroinflammation and neurodegeneration. The long-term neurological consequences pose significant clinical and societal challenges, requiring multidisciplinary care and tailored rehabilitation strategies. This review summarizes current knowledge on the neurological manifestations of COVID-19, underlying mechanisms, and therapeutic approaches, aiming to inform evidence-based post-COVID care.

10 May 2026 in Quality in Sport
Verified
Journal Article
Open access
JKJulia Kociuba
Julia Kociuba
ZKZuzanna Kruczek
Zuzanna Kruczek
MKMartyna Kudła
Martyna Kudła
AKAgata Krawczyk
Agata Krawczyk
NPNatalia Pawełczak
Natalia Pawełczak
GZGabriela Zając
Gabriela Zając
Background. Obesity is a complex neuroendocrine disease requiring long-term management. The emergence of GLP-1 receptor agonists has revolutionized weight loss outcomes; however, pharmacological monotherapy often leads to significant lean body mass (LBM) loss and metabolic adaptation. Aim. To analyze the clinical synergy between incretin-based pharmacotherapy and sports medicine protocols, focusing on functional tissue preservation and long-term metabolic health. Material and methods. A comprehensive review of scientific literature (2021–2026) was conducted, incorporating data from phase III clinical trials (STEP, SURMOUNT, SELECT) and exercise physiology research during pharmacological weight loss. Results. GLP-1 RA monotherapy results in LBM loss comprising 20–40% of total weight reduction. Structured resistance and aerobic training mitigates this loss, enhances muscle quality, and preserves bone mineral density. Combined therapy achieves superior visceral fat reduction and attenuates systemic inflammation while maintaining a higher basal metabolic rate compared to pharmacotherapy alone. Conclusions. Integrating sports medicine with modern pharmacotherapy represents a new standard in obesity treatment. Physical activity serves as a "metabolic anchor," preventing weight regain and improving patients' health-related quality of life (HRQoL).

13 May 2026 in Quality in Sport
Verified
Journal Article
Open access
ZKZuzanna Kruczek
Zuzanna Kruczek
MKMartyna Kudła
Martyna Kudła
JKJulia Kociuba
Julia Kociuba
AKAgata Krawczyk
Agata Krawczyk
DKDorota Kołkowicz
Dorota Kołkowicz
MDMaria Drozd
Maria Drozd
Background. Axial spondyloarthritis (axSpA) is a chronic inflammatory disease affecting the spine and sacroiliac joints. In athletes, clinical identification is difficult due to symptomatic overlap with mechanical overuse and specific behavioral patterns of professional competitors. Aim. This review evaluates diagnostic hurdles of axSpA in athletes and analyzes medical management quality based on evidence from 2021–2026. Material and methods. Following SANRA guidelines, a systematic search of PubMed and Google Scholar was performed, focusing on peer-reviewed literature at the intersection of inflammatory diseases and sports medicine. Results. The athletic culture of enduring pain contributes to a diagnostic delay often exceeding seven years. Professional athletes frequently present with exercise-induced bone marrow edema on MRI, which can mimic active sacroiliitis. Effective management requires a multidisciplinary approach integrating modern pharmacotherapy with specialized physiotherapy, adhering to 2022 ASAS-EULAR recommendations and WADA regulations. Conclusions. A research gap exists regarding prospective studies in elite athletes. Improving care quality necessitates specialized screening protocols to differentiate physiological adaptations from systemic inflammation, ensuring career longevity and high quality of life.

9 June 2026 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
SKSzymon Kurciński
Szymon Kurciński
JSJulia Sinkowska
Julia Sinkowska
MKMartyna Kudła
Martyna Kudła
PCPaweł Czechowicz
Paweł Czechowicz
JCJustyna Czechowicz
Justyna Czechowicz
MAMikołaj Antkiewicz
Mikołaj Antkiewicz
Background: Colorectal cancer (CRC) is the second leading cause of cancer mortality. Modifiable factors, primarily physical inactivity, account for 70% of cases. Physical activity (PA) reduces CRC risk by 20–25%, yet precise molecular pathways require synthesis to refine prevention. Aim: To synthesize biological mechanisms of PA in CRC mitigation and evaluate optimal intensity, dose, and sedentary behavior impact for targeted recommendations. Materials and Methods: A literature review (PubMed, Scopus; 2008–2024) was conducted, integrating meta-analyses and clinical guidelines on the insulin/IGF-1 axis, myokine signaling, and gut microbiota metagenomics. Results: Four pathways were identified: 1) Metabolic: modulation of insulin/IGF-1 axis and sensitivity, 2) Immunological: reduced visceral adiposity and inflammation via myokines and NK-cell surveillance, 3) Mechanical: accelerated transit and improved bile acid metabolism, 4) Microbial: increased butyrate-producing bacteria and mucosal integrity; Protection follows a dose-response relationship, peaking at >300 min/week, especially combining aerobic and resistance training. Interrupting sedentary behavior is a critical independent factor for colonic niche health. Conclusions: PA acts as a systemic biological intervention that inhibits the initiation of neoplastic transformation. Maximum risk reduction requires multimodal training (aerobic and resistance) and the mitigation of prolonged sedentary behavior. "Precision Exercise Oncology" should prioritize individualized prescriptions based on molecular and genetic profiles.